Suramin toxicity and efficacy in agnogenic myeloid metaplasia

J Natl Cancer Inst. 1993 Sep 15;85(18):1520-2. doi: 10.1093/jnci/85.18.1520.
No abstract available

Publication types

  • Case Reports
  • Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myeloproliferative Disorders / drug therapy*
  • Suramin / blood
  • Suramin / toxicity*

Substances

  • Suramin